2,3-substituted fused bicyclic pyrimidin4(3H)-ones which modulate the function of the vanilloid-1 receptor (VR1)

Details for Australian Patent Application No. 2006245520 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Jones, A. Brian; Brown, Rebecca Elizabeth; Bayliss, Tracy; Hollingworth, Gregory John

Agent Spruson & Ferguson

Pub. Number AU-B-2006245520

PCT Pub. Number WO2006/120481

Priority 0509573.2 11.05.05 GB

Filing date 10 May 2006

Wipo publication date 16 November 2006

Acceptance publication date 21 July 2011

International Classifications

C07D 473/04 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

8 November 2007 PCT application entered the National Phase

  PCT publication WO2006/120481 Priority application(s): WO2006/120481

21 July 2011 Application Accepted

  Published as AU-B-2006245520

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006245521-Fixator or splint

2006245519-Tiling adhesive applicator